Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study
- 7 June 2017
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (8) , 2102-2112
Abstract
Background The incidence of inflammatory bowel disease (IBD) is increasing in East Asia; however, population-based data from this region are lacking. Aim We conducted a nationwide, population-based study to examine the incidence and disease course of IBD in South Korea. Methods Using the National Health Insurance claims data, we collected data on patients diagnosed with IBD [10,049 with ulcerative colitis (UC) and 5595 with Crohn’s disease (CD)] from 2011 to 2014. Results During the study period, the average annual incidence of UC was 5.0 per 105, while that of CD was 2.8 per 105. Among patients with UC, the cumulative rates of surgery 1 and 4 years after diagnosis were 1.0 and 2.0%; those among patients with CD were 9.0 and 13.9%, respectively. The 1- and 4-year cumulative rates of moderate- to high-dose corticosteroid use were, respectively, 26.6 and 45.2% among patients with UC, and 29.9 and 50.8% among those with CD. Similarly, the 1- and 4-year cumulative rates of immunomodulator use were 14.1 and 26.4% among patients with UC, and 58.3 and 76.1% among those with CD, respectively. With regard to biologic use, the 1- and 4-year cumulative rates were 3.0 and 9.0% among patients with UC, and 11.1 and 31.7% among those with CD, respectively. Conclusions The recent incidence of IBD in South Korea has been the highest in East Asia. Patients who had been diagnosed recently with IBD showed lower rates of surgery and higher rates of immunomodulator and biologic use compared to those reported ever in South Korea.Keywords
Funding Information
- Ministry of Health and Welfare of the Republic of Korea (A120176, HI13C1345)
- Basic Science Research Program of the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT, and Future Planning (NRF-2013R1A2A2A01067123, NRF-2014R1A1A1008096)
- Yonsei University College of Medicine (2012-31-0477)
This publication has 34 references indexed in Scilit:
- Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from KoreaIntestinal Research, 2016
- Long-term Prognosis of Crohnʼs Disease and Its Temporal Change Between 1981 and 2012Inflammatory Bowel Diseases, 2014
- Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based StudiesGastroenterology, 2013
- Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011Gut, 2013
- Conventional Medical Management of Inflammatory Bowel DiseaseGastroenterology, 2011
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- Clinical features and natural history of ulcerative colitis in KoreaInflammatory Bowel Diseases, 2007
- The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based StudyAmerican Journal of Gastroenterology, 2006
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, central ChinaInflammatory Bowel Diseases, 2006